rss
Br J Ophthalmol 2003;87:1432 doi:10.1136/bjo.87.11.1432
  • Mailbox

Thermochemotherapy in hereditary retinoblastoma

  1. R Murthy,
  2. S G Honavar,
  3. M Naik,
  4. V A P Reddy
  1. Ocular Oncology Service, LV Prasad Eye Institute, Hyderabad, India
  1. Correspondence to: Santosh G Honavar MD, Ocular Oncology Service, LV Prasad Eye Institute, LV Prasad Marg, Banjara Hills, Hyderabad 500 034, India; honavarlvpeye.stph.net
  • Accepted 21 April 2003

Schueler and associates describe their experience with thermochemotherapy (TCT) in bilateral retinoblastoma.1 The reported results of transpupillary thermotherapy used in combination with chemotherapy are encouraging, with 86–96% tumour control.2,3 In the current series, however, local recurrence occurred in 38%.

The dosage of carboplatin used in the current series was 10 mg/kg body weight, which is lower than the standard dosage of …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.